Skip to main content
All lobbying filings

PRIME THERAPEUTICS

Lobbying for PRIME THERAPEUTICS

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · Minnesota · House · Senate · $100,000.00 expenses · posted Jan 20, 2026

Official filing document

 Bills named in this filing 13
  • S 891
    Bipartisan Health Care Act
  • HR 2214
    DRUG Act
  • HR 5378
    Tribal Healthcare Careers Act
  • S 526
    Pharmacy Benefit Manager Transparency Act of 2025
  • S 2305
    FRONT Act
  • HR 5526
    Biosimilar Red Tape Elimination Act
  • HR 4317
    PBM Reform Act of 2025
  • S 3159
    Preserving Patient Access to Long-Term Care Pharmacies Act
  • HR 5031
    Preserving Patient Access to Long-Term Care Pharmacies Act
  • HR 9096
    Deport the Terrorists Act of 2026
  • S 3345
    PBM Price Transparency and Accountability Act
  • HR 6703
    Lower Health Care Premiums for All Americans Act
  • HR 10445
    Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
 Lobbying activity 2
Health Issues

S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation H.R. 10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers H.R. 2214, The DRUG Act -provisions related to PBM compensation H.R. 5378 (118th Congress), Lower Cost, More Transparency Act S. 526 Pharmacy Benefit Manger Transparency Act of 2025 -provisions related to transparency and pharmacy and PBM compensation S, 1339 PBM Reform Act (118th Congress) provisions related to PBM compensation S. 2305/H.R. 5526 The Biosimilar Red Tape Elimination Act-- To improve the requirements for making a determination of interchangeability of a biological product and its reference product. Education on real time benefits checks for prescriptions

Medicare/Medicaid

S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation S. 891, The Bipartisan Health Care Act, provisions related to PBM regulation H.R. 10445 (118th Congress), Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers H.R. 5378 (118th Congress), Lower Cost, More Transparency Act H.R. 4317, PBM Reform Act of 2025 legislation on PBM reform in Medicare and pharmacy access standards S. 3159/H.R. 5031 Preserving Patient Access to Long Term Care Pharmacies Act provision designed to ensure continued access to essential medications and pharmacy services for seniors in long- term care facilities by establishing a temporary supply fee for pharmacies. H.R. 9096 Pharmacists Fight Back Act legislation to establish pharmacy payment, transparency requirements and reimbursement by pharmacy benefits managers in federal programs S.3345 - PBM Price Transparency and Accountability Act -provisions reforming PBM practices in Medicare in Medicaid including delinking, a ban on Medicaid spread pricing, transparency and audit rights H.R. 6703, the Lower Health Care Premiums for All Americans Act -provisions addressing PBM practices in Medicare and Medicaid

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem